Furthermore, recent evidence demonstrated that stromal nicotinamide N-methyltransferase (NNMT), an enzyme that impairs NAD+ biosynthesis by depleting its precursor N-nicotinamide, induces CAF differentiation and cancer progression (Eckert et al., 2019). Here, NNMT is linked to cancer.